ATE496628T1 - Verwendung von lecithin als arzneimittel zur behandlung von psoriasis - Google Patents
Verwendung von lecithin als arzneimittel zur behandlung von psoriasisInfo
- Publication number
- ATE496628T1 ATE496628T1 AT06743672T AT06743672T ATE496628T1 AT E496628 T1 ATE496628 T1 AT E496628T1 AT 06743672 T AT06743672 T AT 06743672T AT 06743672 T AT06743672 T AT 06743672T AT E496628 T1 ATE496628 T1 AT E496628T1
- Authority
- AT
- Austria
- Prior art keywords
- lecithin
- treat psoriasis
- medicine
- marine
- composition
- Prior art date
Links
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 title abstract 2
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- 229940067606 lecithin Drugs 0.000 title abstract 2
- 235000010445 lecithin Nutrition 0.000 title abstract 2
- 239000000787 lecithin Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0503827A FR2884425B3 (fr) | 2005-04-18 | 2005-04-18 | Composition pharmaceutique destinee a soigner le psoriasis |
| FR0506496A FR2884423B1 (fr) | 2005-04-18 | 2005-06-27 | Utilisation de la lecithine comme medicament dans le traitement du psoriasis |
| PCT/FR2006/000792 WO2006111633A2 (fr) | 2005-04-18 | 2006-04-11 | Utilisation de la lecithine comme medicament dans le traitement du psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE496628T1 true ATE496628T1 (de) | 2011-02-15 |
Family
ID=35463696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06743672T ATE496628T1 (de) | 2005-04-18 | 2006-04-11 | Verwendung von lecithin als arzneimittel zur behandlung von psoriasis |
Country Status (4)
| Country | Link |
|---|---|
| AT (1) | ATE496628T1 (de) |
| DE (1) | DE602006019842D1 (de) |
| ES (1) | ES2359987T3 (de) |
| FR (2) | FR2884425B3 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108004016A (zh) * | 2017-12-18 | 2018-05-08 | 青岛康境海洋生物科技有限公司 | 一种高卵磷脂含量的南极磷虾油的制备方法 |
| CN113995763B (zh) * | 2021-11-10 | 2023-08-11 | 中南大学湘雅医院 | 磷脂酰乙醇胺作为活性成分在制备银屑病治疗药物中的应用、银屑病治疗药物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998042348A1 (en) * | 1997-03-25 | 1998-10-01 | Wilson Trafton Crandall | Topical moisturizing composition and method |
| US20020012648A1 (en) * | 1998-02-06 | 2002-01-31 | Orthoefer Frank T. | High phospholipid-containing dermatological compositions |
| WO2005002591A1 (en) * | 2003-07-02 | 2005-01-13 | Fouad Abdelaziz Ahmed Hassanin | Treatment psoriasis, impetigo, tinea by lipositol, cephalin and lecithin |
-
2005
- 2005-04-18 FR FR0503827A patent/FR2884425B3/fr not_active Expired - Lifetime
- 2005-06-27 FR FR0506496A patent/FR2884423B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-11 DE DE602006019842T patent/DE602006019842D1/de active Active
- 2006-04-11 ES ES06743672T patent/ES2359987T3/es active Active
- 2006-04-11 AT AT06743672T patent/ATE496628T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2359987T3 (es) | 2011-05-30 |
| FR2884425A1 (fr) | 2006-10-20 |
| FR2884423A1 (fr) | 2006-10-20 |
| FR2884423B1 (fr) | 2007-06-22 |
| FR2884425B3 (fr) | 2007-05-25 |
| DE602006019842D1 (de) | 2011-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Han et al. | Anti-photoaging effect of hydrolysates from pacific whiting skin via MAPK/AP-1, NF-κB, TGF-β/Smad, and Nrf-2/HO-1 signaling pathway in UVB-induced human dermal fibroblasts | |
| PE20050255A1 (es) | Nuevas cianotiazolidas y procedimiento para su preparacion como medicamentos | |
| EA200901555A1 (ru) | Композиция местного применения по уходу за кожей и способ лечения | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
| Măgerușan et al. | A comprehensive bibliographic review concerning the efficacy of organic acids for chemical peels treating acne vulgaris | |
| EA200601212A1 (ru) | Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение | |
| ATE489935T1 (de) | Verwendung von glycyrrhetinsäure und/oder glycyrrhizin zur herstellung von zubereitungen zur bräunung der haut | |
| ATE495728T1 (de) | Kosmetische oder dermatologische zubereitungen mit n-acetylcystein | |
| DE502004008819D1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
| Lee et al. | Identification of L-cysteinamide as a potent inhibitor of tyrosinase-mediated dopachrome formation and eumelanin synthesis | |
| Kang et al. | UP256 inhibits hyperpigmentation by tyrosinase expression/dendrite formation via rho-dependent signaling and by primary cilium formation in melanocytes | |
| ATE510536T1 (de) | Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen | |
| ATE438623T1 (de) | Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes | |
| CY1111353T1 (el) | Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης | |
| DE502005008971D1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht | |
| Joyjamras et al. | Recycled Sericin Hydrolysates Modified by Alcalase® Suppress Melanogenesis in Human Melanin-Producing Cells via Modulating MITF | |
| Yeom et al. | The alleviating effect of Lagerstroemia indica flower extract on stretch marks through regulation of mast cells | |
| NO20075199L (no) | Treatment or prevention of pruritus | |
| EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
| ATE507226T1 (de) | 1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung | |
| ATE496628T1 (de) | Verwendung von lecithin als arzneimittel zur behandlung von psoriasis | |
| BRPI0507321A (pt) | derivados de 7-amino-4-quinolona-3-ácido carboxìlico substituìdos com cicloalquila, processos para produção dos mesmos e uso dos mesmos como medicamento | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης | |
| EA201070478A1 (ru) | Дифенилкарбоновые кислоты и их производные |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |